Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “BOARD OF REGENTS”

2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,639
Index total 30,257
Page 39 / 110

Quick answer

This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,639 results for “BOARD OF REGENTS” · 30,257 patents in full index Clear search

  1. US 10434075

    FKBP52 specific androgen receptor inhibitor, MJC13, for use in treating breast cancer

    The Board of Regents of the University of Texas System · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted

  2. US 10434062

    Compositions and methods of making brittle-matrix particles through blister pack freezing

    The Board of Regents of the University of Texas System · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted

  3. US 10435435

    Quinstatin compounds

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted

  4. US 10428115

    Dynorphin A analogs with bradykinin receptors specificity for modulation of neuropathic pain

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted

  5. US 10428159

    Blocking monoclonal antibodies to AGR2 and its receptor C4.4A

    The Board of Regents of the University of Texas System · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted

  6. US 10428057

    Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted

  7. US 10420758

    Indolinyl-sulfonamide inhibitors of tankyrase and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted

  8. US 10421765

    Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase

    The Board of Regents of the University of Texas System · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted

  9. US 10420833

    Combinatorial platform for the display of surface adjuvants and antigens

    The Board of Regents of the University of Texas System · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted

  10. US 10420720

    Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief

    The Board of Regents of the University of Texas System · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted

  11. US 10416174

    Diagnosis and prognosis for chronic fatigue syndrome

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted

  12. US 10413602

    Fungal immunogens and related materials and methods

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted

  13. US 10414725

    Pyrrolomycins and methods of using the same

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted

  14. US 10407495

    Bispecific antibody fragments for neurological disease proteins and methods of use

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  15. US 10406248

    Molecular imaging of cancer cells in vivo

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  16. US 10406167

    Texaphyrin-Pt(IV) conjugates and compositions for use in overcoming platinum resistance

    The Board of Regents of the University of Texas System · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  17. US 10398682

    Methods and compositions to prevent or treat bacterial infections

    The Board of Regents of the University of Texas System · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted

  18. US 10398661

    Methods for classifying a cancer as susceptible to TMEPAI-directed therapies and treating such cancers

    The Board of Regents of the University of Texas System · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted

  19. US 10398668

    Glutamate treatment of cardiovascular disorders

    The Board of Regents of the University of Oklahoma · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted

  20. US 10398749

    Methods of treating muscular dystrophy

    BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted

  21. US 10398680

    Methods of treating muscular dystrophy

    BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted

  22. US 10391183

    Infectivity-enhanced conditionally-replicative adenovirus and uses thereof

    The Board of Regents of the University of Texas System · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted

  23. US 10392618

    Micro-RNA family that modulates extracellular matrix genes and uses thereof

    The Board of Regents of the University of Texas System · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted

  24. US 10391093

    Therapeutic compounds

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.